CBIZ (NYSE:CBZ – Get Free Report) issued its quarterly earnings results on Thursday. The business services provider reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.29), Briefing.com reports. The business had revenue of $420.00 million during the quarter, compared to analyst estimates of $430.38 million. CBIZ had a return on equity of 14.88% and a net margin of 7.12%. The firm’s quarterly revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.55 earnings per share.
CBIZ Trading Down 2.7 %
Shares of CBIZ stock traded down $2.00 during trading hours on Friday, reaching $71.05. The stock had a trading volume of 789,115 shares, compared to its average volume of 399,357. The firm has a 50 day simple moving average of $77.02 and a two-hundred day simple moving average of $74.52. The firm has a market capitalization of $3.56 billion, a price-to-earnings ratio of 28.77 and a beta of 0.93. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.50. CBIZ has a 1 year low of $49.15 and a 1 year high of $86.36.
Analyst Ratings Changes
Separately, StockNews.com downgraded CBIZ from a “hold” rating to a “sell” rating in a report on Tuesday, July 16th.
About CBIZ
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
See Also
- Five stocks we like better than CBIZ
- About the Markup Calculator
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- What is a Secondary Public Offering? What Investors Need to Know
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.